Top

Published in:

Open Access 01-07-2018 | Review

The roles for innate lymphoid cells in the human immune system

Authors: L. Mazzurana, A. Rao, A. Van Acker, J. Mjösberg

Published in: Seminars in Immunopathology | Issue 4/2018

Abstract

From constituting a novel and obscure cell population, innate lymphoid cells (ILCs) are now accepted as a self-evident part of the immune system, contributing with unique and complementary functions to immunity by production of effector cytokines and interaction with other cell types. In this review, we discuss the redundant and complementary roles of the highly plastic human ILCs and their interaction with other immune cells with the ultimate aim of placing ILCs in a wider context within the human immune system.

Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, Koyasu S, Locksley RM, McKenzie ANJ, Mebius RE, Powrie F, Vivier E (2013) Innate lymphoid cells—a proposal for uniform nomenclature. Nat. Rev. Immunol. 13:145–149. https://doi.org/10.1038/nri3365 PubMedCrossRef

Klose CSN, Flach M, Möhle L, Rogell L, Hoyler T, Ebert K, Fabiunke C, Pfeifer D, Sexl V, Fonseca-Pereira D, Domingues RG, Veiga-Fernandes H, Arnold SJ, Busslinger M, Dunay IR, Tanriver Y, Diefenbach A (2014) Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 157:340–356. https://doi.org/10.1016/J.CELL.2014.03.030 PubMedCrossRef

Eberl G, Marmon S, Sunshine M-J, Rennert PD, Choi Y, Littman DR (2004) An essential function for the nuclear receptor RORγt in the generation of fetal lymphoid tissue inducer cells. Nat Immunol 5:64–73. https://doi.org/10.1038/ni1022 PubMedCrossRef

Mebius RE, Rennert P, Weissman IL (1997) Developing lymph nodes collect CD4+CD3- LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 7:493–504 http://www.ncbi.nlm.nih.gov/pubmed/9354470 (accessed 27 Feb 2018)PubMedCrossRef

Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, Kawamoto H, Furusawa J, Ohtani M, Fujii H, Koyasu S (2010) Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells. Nature 463:540–544. https://doi.org/10.1038/nature08636 PubMedCrossRef

Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, Langford TKA, Bucks C, Kane CM, Fallon PG, Pannell R, Jolin HE, McKenzie ANJ (2010) Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464:1367–1370. https://doi.org/10.1038/nature08900 PubMedPubMedCentralCrossRef

Price AE, Liang H-E, Sullivan BM, Reinhardt RL, Eisley CJ, Erle DJ, Locksley RM (2010) Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci U S A 107:11489–11494. https://doi.org/10.1073/pnas.1003988107 PubMedPubMedCentralCrossRef

Mjösberg JM, Trifari S, Crellin NK, Peters CP, van Drunen CM, Piet B, Fokkens WJ, Cupedo T, Spits H (2011) Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 12:1055–1062. https://doi.org/10.1038/ni.2104 PubMedCrossRef

Bernink JH, Peters CP, Munneke M, te Velde AA, Meijer SL, Weijer K, Hreggvidsdottir HS, Heinsbroek SE, Legrand N, Buskens CJ, Bemelman WA, Mjösberg JM, Spits H (2013) Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat Immunol 14:221–229. https://doi.org/10.1038/ni.2534 PubMedCrossRef

10.

Cupedo T, Crellin NK, Papazian N, Rombouts EJ, Weijer K, Grogan JL, Fibbe WE, Cornelissen JJ, Spits H (2009) Human fetal lymphoid tissue-inducer cells are interleukin 17-producing precursors to RORC+ CD127+ natural killer-like cells. Nat Immunol 10:66–74. https://doi.org/10.1038/ni.1668 PubMedCrossRef

11.

Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CGK, Doering TA, Angelosanto JM, Laidlaw BJ, Yang CY, Sathaliyawala T, Kubota M, Turner D, Diamond JM, Goldrath AW, Farber DL, Collman RG, Wherry EJ, Artis D (2011) Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat Immunol 12:1045–1054. https://doi.org/10.1031/ni.2131. PubMedPubMedCentralCrossRef

12.

Klose CSN, Artis D (2016) Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis. Nat Immunol 17:765–774. https://doi.org/10.1038/ni.3489 PubMedCrossRef

13.

Gasteiger G, Fan X, Dikiy S, Lee SY, Rudensky AY (2015) Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs. Science 350:981–985. https://doi.org/10.1126/science.aac9593 PubMedPubMedCentralCrossRef

14.

Huang Y, Mao K, Chen X, Sun M, Kawabe T, Li W, Usher N, Zhu J, Urban JF, Paul WE, Germain RN (2018) S1P-dependent interorgan trafficking of group 2 innate lymphoid cells supports host defense. Science (80-.) 359:114–119. https://doi.org/10.1126/science.aam5809 CrossRef

15.

Mjösberg J, Spits H (2016) Human innate lymphoid cells. J Allergy Clin Immunol 138:1265–1276. https://doi.org/10.1016/j.jaci.2016.09.009 PubMedCrossRef

16.

Björkström NK, Ljunggren H-G, Michaëlsson J (2016) Emerging insights into natural killer cells in human peripheral tissues. Nat Rev Immunol 16:310–320. https://doi.org/10.1038/nri.2016.34 PubMedCrossRef

17.

Bernink JH, Krabbendam L, Germar K, de Jong E, Gronke K, Kofoed-Nielsen M, Munneke JM, Hazenberg MD, Villaudy J, Buskens CJ, Bemelman WA, Diefenbach A, Blom B, Spits H (2015) Interleukin-12 and -23 control plasticity of CD127+ group 1 and group 3 innate lymphoid cells in the intestinal lamina propria. Immunity 43:146–160. https://doi.org/10.1016/j.immuni.2015.06.019 PubMedCrossRef

18.

Klose CSN, Kiss EA, Schwierzeck V, Ebert K, Hoyler T, d’Hargues Y, Göppert N, Croxford AL, Waisman A, Tanriver Y, Diefenbach A (2013) A T-bet gradient controls the fate and function of CCR6−RORγt+ innate lymphoid cells. Nature 494:261–265. https://doi.org/10.1038/nature11813 PubMedCrossRef

19.

Powell N, Walker AW, Stolarczyk E, Canavan JB, Gökmen MR, Marks E, Jackson I, Hashim A, Curtis MA, Jenner RG, Howard JK, Parkhill J, MacDonald TT, Lord GM (2012) The transcription factor T-bet regulates intestinal inflammation mediated by interleukin-7 receptor+ innate lymphoid cells. Immunity 37:674–684. https://doi.org/10.1016/J.IMMUNI.2012.09.008 PubMedPubMedCentralCrossRef

20.

Simoni Y, Fehlings M, Kløverpris HN, McGovern N, Koo S-L, Loh CY, Lim S, Kurioka A, Fergusson JR, Tang C-L, Kam MH, Dennis K, Lim TKH, Fui ACY, Hoong CW, Chan JKY, Curotto de Lafaille M, Narayanan S, Baig S, Shabeer M, Toh S-AES, Tan HKK, Anicete R, Tan E-H, Takano A, Klenerman P, Leslie A, Tan DSW, Tan IB, Ginhoux F, Newell EW (2017) Human innate lymphoid cell subsets possess tissue-type based heterogeneity in phenotype and frequency. Immunity 46:148–161. https://doi.org/10.1016/j.immuni.2016.11.005 PubMedCrossRef

21.

Bernink JH, Mjösberg J, Spits H (2017) Human ILC1: to be or not to be. Immunity 46:756–757. https://doi.org/10.1016/j.immuni.2017.05.001 PubMedPubMedCentralCrossRef

22.

Simoni Y, Newell EW (2017) Toward meaningful definitions of innate-lymphoid-cell subsets. Immunity 46:760–761. https://doi.org/10.1016/j.immuni.2017.04.026 PubMedCrossRef

23.

Björklund ÅK, Forkel M, Picelli S, Konya V, Theorell J, Friberg D, Sandberg R, Mjösberg J (2016) The heterogeneity of human CD127+ innate lymphoid cells revealed by single-cell RNA sequencing. Nat Immunol 17:451–460. https://doi.org/10.1038/ni.3368 PubMedCrossRef

24.

Roan F, Stoklasek TA, Whalen E, Molitor JA, Bluestone JA, Buckner JH, Ziegler SF (2016) CD4 ⁺ group 1 innate lymphoid cells (ILC) form a functionally distinct ILC subset that is increased in systemic sclerosis. J Immunol 196:2051–2062. https://doi.org/10.4049/jimmunol.1501491 PubMedPubMedCentralCrossRef

25.

Brestoff JR, Kim BS, Saenz SA, Stine RR, Monticelli LA, Sonnenberg GF, Thome JJ, Farber DL, Lutfy K, Seale P, Artis D (2015) Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 519:242–246. https://doi.org/10.1038/nature14115 PubMedCrossRef

26.

Mjösberg J, Bernink J, Golebski K, Karrich JJ, Peters CP, Blom B, te Velde AA, Fokkens WJ, van Drunen CM, Spits H (2012) The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells. Immunity 37:649–659. https://doi.org/10.1016/J.IMMUNI.2012.08.015 PubMedCrossRef

27.

Maazi H, Patel N, Sankaranarayanan I, Suzuki Y, Rigas D, Soroosh P, Freeman GJ, Sharpe AH, Akbari O (2015) ICOS:ICOS-ligand interaction is required for type 2 innate lymphoid cell function, homeostasis, and induction of airway hyperreactivity. Immunity 42:538–551. https://doi.org/10.1016/j.immuni.2015.02.007 PubMedPubMedCentralCrossRef

28.

Salimi M, Xue L, Jolin H, Hardman C, Cousins DJ, McKenzie ANJ, Ogg GS (2016) Group 2 innate lymphoid cells express functional NKp30 receptor inducing type 2 cytokine production. J Immunol 196:45–54. https://doi.org/10.4049/jimmunol.1501102 PubMedCrossRef

29.

Konya V, Mjösberg J (2016) Lipid mediators as regulators of human ILC2 function in allergic diseases. Immunol Lett 179:36–42. https://doi.org/10.1016/J.IMLET.2016.07.006 PubMedCrossRef

30.

Maric J, Ravindran A, Mazzurana L, Björklund ÅK, Van Acker A, Rao A, Friberg D, Dahlén S-E, Heinemann A, Konya V, Mjösberg J (2017) Prostaglandin E 2 suppresses human group 2 innate lymphoid cell function. J Allergy Clin Immunol 141:1761–1773.e6. https://doi.org/10.1016/j.jaci.2017.09.050 PubMedCrossRef

31.

Xue L, Salimi M, Panse I, Mjösberg JM, McKenzie ANJ, Spits H, Klenerman P, Ogg G (2014) Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells. J Allergy Clin Immunol 133:1184–1194. https://doi.org/10.1016/j.jaci.2013.10.056 PubMedPubMedCentralCrossRef

32.

Halim TYF, Krauß RH, Sun AC, Takei F (2012) Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation. Immunity 36:451–463. https://doi.org/10.1016/J.IMMUNI.2011.12.020 PubMedCrossRef

33.

Wilhelm C, Hirota K, Stieglitz B, Van Snick J, Tolaini M, Lahl K, Sparwasser T, Helmby H, Stockinger B (2011) An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat Immunol 12:1071–1077. https://doi.org/10.1038/ni.2133 PubMedPubMedCentralCrossRef

34.

Chang Y-J, Kim HY, Albacker LA, Baumgarth N, McKenzie ANJ, Smith DE, DeKruyff RH, Umetsu DT (2011) Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol 12:631–638. https://doi.org/10.1038/ni.2045 PubMedPubMedCentralCrossRef

35.

Hong JY, Bentley JK, Chung Y, Lei J, Steenrod JM, Chen Q, Sajjan US, Hershenson MB (2014) Neonatal rhinovirus induces mucous metaplasia and airways hyperresponsiveness through IL-25 and type 2 innate lymphoid cells. J Allergy Clin Immunol 134:429–439. https://doi.org/10.1016/j.jaci.2014.04.020 PubMedPubMedCentralCrossRef

36.

Barlow JL, Bellosi A, Hardman CS, Drynan LF, Wong SH, Cruickshank JP, McKenzie ANJ (2012) Innate IL-13–producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. J Allergy Clin Immunol 129:191–198.e4. https://doi.org/10.1016/J.JACI.2011.09.041 PubMedCrossRef

37.

Bal SM, Bernink JH, Nagasawa M, Groot J, Shikhagaie MM, Golebski K, van Drunen CM, Lutter R, Jonkers RE, Hombrink P, Bruchard M, Villaudy J, Munneke JM, Fokkens W, Erjefält JS, Spits H, Ros XR (2016) IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. Nat Immunol 17:636–645. https://doi.org/10.1038/ni.3444 PubMedCrossRef

38.

Shaw JL, Fakhri S, Citardi MJ, Porter PC, Corry DB, Kheradmand F, Liu Y-J, Luong A (2013) IL-33-responsive innate lymphoid cells are an important source of IL-13 in chronic rhinosinusitis with nasal polyps. Am J Respir Crit Care Med 188:432–439. https://doi.org/10.1164/rccm.201212-2227OC PubMedPubMedCentralCrossRef

39.

Smith SG, Chen R, Kjarsgaard M, Huang C, Oliveria J-P, O’Byrne PM, Gauvreau GM, Boulet L-P, Lemiere C, Martin J, Nair P, Sehmi R (2016) Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia. J Allergy Clin Immunol 137:75–86.e8. https://doi.org/10.1016/j.jaci.2015.05.037 PubMedCrossRef

40.

Nagakumar P, Denney L, Fleming L, Bush A, Lloyd CM, Saglani S (2016) Type 2 innate lymphoid cells in induced sputum from children with severe asthma. J Allergy Clin Immunol 137:624–626.e6. https://doi.org/10.1016/j.jaci.2015.06.038 PubMedCrossRef

41.

Christianson CA, Goplen NP, Zafar I, Irvin C, Good JT, Rollins DR, Gorentla B, Liu W, Gorska MM, Chu H, Martin RJ, Alam R (2015) Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33. J Allergy Clin Immunol 136:59–68.e14. https://doi.org/10.1016/j.jaci.2014.11.037 PubMedPubMedCentralCrossRef

42.

Rak GD, Osborne LC, Siracusa MC, Kim BS, Wang K, Bayat A, Artis D, Volk SW (2016) IL-33-dependent group 2 innate lymphoid cells promote cutaneous wound healing. J. Invest. Dermatol. 136:487–496. https://doi.org/10.1038/JID.2015.406 PubMedPubMedCentralCrossRef

43.

Huang Y, Guo L, Qiu J, Chen X, Hu-Li J, Siebenlist U, Williamson PR, Urban JF, Paul WE (2014) IL-25-responsive, lineage-negative KLRG1hi cells are multipotential “inflammatory” type 2 innate lymphoid cells. Nat Immunol 16:161–169. https://doi.org/10.1038/ni.3078 PubMedPubMedCentralCrossRef

44.

Seehus CR, Kadavallore A, de la Torre B, Yeckes AR, Wang Y, Tang J, Kaye J (2017) Alternative activation generates IL-10 producing type 2 innate lymphoid cells. Nat Commun 8:1900. https://doi.org/10.1038/s41467-017-02023-z PubMedPubMedCentralCrossRef

45.

Qiu J, Heller JJ, Guo X, Chen ZE, Fish K, Fu Y-X, Zhou L (2012) The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 36:92–104. https://doi.org/10.1016/j.immuni.2011.11.011. PubMedCrossRef

46.

Hoorweg K, Peters CP, Cornelissen F, Aparicio-Domingo P, Papazian N, Kazemier G, Mjösberg JM, Spits H, Cupedo T (2012) Functional differences between human NKp44(−) and NKp44(+) RORC(+) innate lymphoid cells. Front Immunol 3:72. https://doi.org/10.3389/fimmu.2012.00072 PubMedPubMedCentralCrossRef

47.

Konya V, Czarnewski P, Forkel M, Rao A, Kokkinou E, Villablanca EJ, Almer S, Lindforss U, Friberg D, Höög C, Bergman P, Mjösberg J (2018) Vitamin D downregulates the IL-23 receptor pathway in human mucosal group 3 innate lymphoid cells. J Allergy Clin Immunol 141:279–292. https://doi.org/10.1016/j.jaci.2017.01.045 PubMedCrossRef

48.

Marquardt N, Ivarsson MA, Sundström E, Åkesson E, Martini E, Eidsmo L, Mjösberg J, Friberg D, Kublickas M, Ek S, Tegerstedt G, Seiger Å, Westgren M, Michaëlsson J (2016) Fetal CD103 ⁺ IL-17–producing group 3 innate lymphoid cells represent the dominant lymphocyte subset in human amniotic fluid. J Immunol 197:3069–3075. https://doi.org/10.4049/jimmunol.1502204 PubMedCrossRef

49.

Sonnenberg GF, Monticelli LA, Elloso MM, Fouser LA, Artis D (2011) CD4+ lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 34:122–134. https://doi.org/10.1016/j.immuni.2010.12.009 PubMedCrossRef

50.

Constantinides MG, McDonald BD, Verhoef PA, Bendelac A (2014) A committed precursor to innate lymphoid cells. Nature 508:397–401. https://doi.org/10.1038/nature13047 PubMedPubMedCentralCrossRef

51.

Shikhagaie MM, Björklund ÅK, Mjösberg J, Erjefält JS, Cornelissen AS, Ros XR, Bal SM, Koning JJ, Mebius RE, Mori M, Bruchard M, Blom B, Spits H (2017) Neuropilin-1 is expressed on lymphoid tissue residing LTi-like group 3 innate lymphoid cells and associated with ectopic lymphoid aggregates. Cell Rep 18:1761–1773. https://doi.org/10.1016/j.celrep.2017.01.063 PubMedPubMedCentralCrossRef

52.

von Burg N, Turchinovich G, Finke D (2015) Maintenance of immune homeostasis through ILC/T cell interactions. Front Immunol 6:416. https://doi.org/10.3389/fimmu.2015.00416 CrossRef

53.

Lim AI, Li Y, Lopez-Lastra S, Stadhouders R, Paul F, Casrouge A, Serafini N, Puel A, Bustamante J, Surace L, Masse-Ranson G, David E, Strick-Marchand H, Le Bourhis L, Cocchi R, Topazio D, Graziano P, Muscarella LA, Rogge L, Norel X, Sallenave J-M, Allez M, Graf T, Hendriks RW, Casanova J-L, Amit I, Yssel H, Di Santo JP (2017) Systemic human ILC precursors provide a substrate for tissue ILC differentiation. Cell 168:1086–1100.e10. https://doi.org/10.1016/j.cell.2017.02.021 PubMedCrossRef

54.

Sawa S, Lochner M, Satoh-Takayama N, Dulauroy S, Bérard M, Kleinschek M, Cua D, Di Santo JP, Eberl G (2011) RORγt+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nat Immunol 12:320–326. https://doi.org/10.1038/ni.2002 PubMedCrossRef

55.

Satoh-Takayama N, Vosshenrich CAJ, Lesjean-Pottier S, Sawa S, Lochner M, Rattis F, Mention J-J, Thiam K, Cerf-Bensussan N, Mandelboim O, Eberl G, Di Santo JP (2008) Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 29:958–970. https://doi.org/10.1016/j.immuni.2008.11.001 PubMedCrossRef

56.

Sonnenberg GF, Monticelli LA, Alenghat T, Fung TC, Hutnick NA, Kunisawa J, Shibata N, Grunberg S, Sinha R, Zahm AM, Tardif MR, Sathaliyawala T, Kubota M, Farber DL, Collman RG, Shaked A, Fouser LA, Weiner DB, Tessier PA, Friedman JR, Kiyono H, Bushman FD, Chang K-M, Artis D (2012) Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 336:1321–1325. https://doi.org/10.1126/science.1222551 PubMedPubMedCentralCrossRef

57.

Gladiator A, Wangler N, Trautwein-Weidner K, LeibundGut-Landmann S (2013) Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection. J Immunol 190:521–525. https://doi.org/10.4049/jimmunol.1202924 PubMedCrossRef

58.

Abt MC, Lewis BB, Caballero S, Xiong H, Carter RA, Sušac B, Ling L, Leiner I, Pamer EG (2015) Innate immune defenses mediated by two ILC subsets are critical for protection against acute Clostridium difficile infection. Cell Host Microbe 18:27–37. https://doi.org/10.1016/j.chom.2015.06.011 PubMedPubMedCentralCrossRef

59.

Goto Y, Obata T, Kunisawa J, Sato S, Ivanov II, Lamichhane A, Takeyama N, Kamioka M, Sakamoto M, Matsuki T, Setoyama H, Imaoka A, Uematsu S, Akira S, Domino SE, Kulig P, Becher B, Renauld J-C, Sasakawa C, Umesaki Y, Benno Y, Kiyono H (2014) Innate lymphoid cells regulate intestinal epithelial cell glycosylation. Science (80-.) 345:1254009–1254009. https://doi.org/10.1126/science.1254009 CrossRef

60.

Van Maele L, Carnoy C, Cayet D, Ivanov S, Porte R, Deruy E, Chabalgoity JA, Renauld J-C, Eberl G, Benecke AG, Trottein F, Faveeuw C, Sirard J-C (2014) Activation of type 3 innate lymphoid cells and interleukin 22 secretion in the lungs during Streptococcus pneumoniae infection. J Infect Dis 210:493–503. https://doi.org/10.1093/infdis/jiu106 PubMedCrossRef

61.

Hernández PP, Mahlakõiv T, Yang I, Schwierzeck V, Nguyen N, Guendel F, Gronke K, Ryffel B, Hölscher C, Dumoutier L, Renauld J-C, Suerbaum S, Staeheli P, Diefenbach A (2015) Interferon-λ and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection. Nat Immunol 16:698–707. https://doi.org/10.1038/ni.3180 PubMedPubMedCentralCrossRef

62.

Turner J-E, Stockinger B, Helmby H (2013) IL-22 mediates goblet cell hyperplasia and worm expulsion in intestinal helminth infection. PLoS Pathog 9:e1003698. https://doi.org/10.1371/journal.ppat.1003698 PubMedPubMedCentralCrossRef

63.

Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, Abbas AR, Modrusan Z, Ghilardi N, de Sauvage FJ, Ouyang W (2008) Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 14:282–289. https://doi.org/10.1038/nm1720 PubMedCrossRef

64.

Guo X, Qiu J, Tu T, Yang X, Deng L, Anders RA, Zhou L, Fu Y-X (2014) Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor STAT3 mediates protection against intestinal infection. Immunity 40:25–39. https://doi.org/10.1016/j.immuni.2013.10.021 PubMedPubMedCentralCrossRef

65.

Buonocore S, Ahern PP, Uhlig HH, Ivanov II, Littman DR, Maloy KJ, Powrie F (2010) Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464:1371–1375. https://doi.org/10.1038/nature08949 PubMedPubMedCentralCrossRef

66.

Kim HY, Lee HJ, Chang Y-J, Pichavant M, Shore SA, Fitzgerald KA, Iwakura Y, Israel E, Bolger K, Faul J, DeKruyff RH, Umetsu DT (2014) Interleukin-17–producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat Med 20:54–61. https://doi.org/10.1038/nm.3423 PubMedCrossRef

67.

Kirchberger S, Royston DJ, Boulard O, Thornton E, Franchini F, Szabady RL, Harrison O, Powrie F (2013) Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J Exp Med 210:917–931. https://doi.org/10.1084/jem.20122308 PubMedPubMedCentralCrossRef

68.

Munneke JM, Björklund AT, Mjösberg JM, Garming-Legert K, Bernink JH, Blom B, Huisman C, van Oers MHJ, Spits H, Malmberg K-J, Hazenberg MD (2014) Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease. Blood 124:812–821. https://doi.org/10.1182/blood-2013-11-536888 PubMedCrossRef

69.

Geremia A, Arancibia-Cárcamo CV, Fleming MPP, Rust N, Singh B, Mortensen NJ, Travis SPL, Powrie F (2011) IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med 208:1127–1133. https://doi.org/10.1084/jem.20101712 PubMedPubMedCentralCrossRef

70.

Teunissen MBM, Munneke JM, Bernink JH, Spuls PI, Res PCM, te Velde A, Cheuk S, Brouwer MWD, Menting SP, Eidsmo L, Spits H, Hazenberg MD, Mjösberg J (2014) Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR + ILC3 in lesional skin and blood of psoriasis patients. J. Invest. Dermatol. 134:2351–2360. https://doi.org/10.1038/jid.2014.146 PubMedCrossRef

71.

Villanova F, Flutter B, Tosi I, Grys K, Sreeneebus H, Perera GK, Chapman A, Smith CH, Di Meglio P, Nestle FO (2014) Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis. J Invest Dermatol 134:984–991. https://doi.org/10.1038/jid.2013.477 PubMedCrossRef

72.

Yang Q, Bhandoola A (2016) The development of adult innate lymphoid cells. Curr Opin Immunol 39:114–120. https://doi.org/10.1016/j.coi.2016.01.006 PubMedPubMedCentralCrossRef

73.

Moretta F, Petronelli F, Lucarelli B, Pitisci A, Bertaina A, Locatelli F, Mingari MC, Moretta L, Montaldo E (2016) The generation of human innate lymphoid cells is influenced by the source of hematopoietic stem cells and by the use of G-CSF. Eur J Immunol 46:1271–1278. https://doi.org/10.1002/eji.201546079 PubMedCrossRef

74.

Scoville SD, Mundy-Bosse BL, Zhang MH, Chen L, Zhang X, Keller KA, Hughes T, Chen L, Cheng S, Bergin SM, Mao HC, McClory S, Yu J, Carson WE, Caligiuri MA, Freud AG (2016) A progenitor cell expressing transcription factor RORγt generates all human innate lymphoid cell subsets. Immunity 44:1140–1150. https://doi.org/10.1016/j.immuni.2016.04.007 PubMedPubMedCentralCrossRef

75.

Montaldo E, Teixeira-Alves LG, Glatzer T, Durek P, Stervbo U, Hamann W, Babic M, Paclik D, Stölzel K, Gröne J, Lozza L, Juelke K, Matzmohr N, Loiacono F, Petronelli F, Huntington ND, Moretta L, Mingari MC, Romagnani C (2014) Human RORγt+CD34+ cells are lineage-specified progenitors of group 3 RORγt+ innate lymphoid cells. Immunity 41:988–1000. https://doi.org/10.1016/j.immuni.2014.11.010 PubMedCrossRef

76.

Lim AI, Menegatti S, Bustamante J, Le Bourhis L, Allez M, Rogge L, Casanova J-L, Yssel H, Di Santo JP (2016) IL-12 drives functional plasticity of human group 2 innate lymphoid cells. J Exp Med 213:569–583. https://doi.org/10.1084/jem.20151750 PubMedPubMedCentralCrossRef

77.

Silver JS, Kearley J, Copenhaver AM, Sanden C, Mori M, Yu L, Pritchard GH, Berlin AA, Hunter CA, Bowler R, Erjefalt JS, Kolbeck R, Humbles AA (2016) Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs. Nat Immunol 17:626–635. https://doi.org/10.1038/ni.3443 PubMedPubMedCentralCrossRef

78.

Ohne Y, Silver JS, Thompson-Snipes L, Collet MA, Blanck JP, Cantarel BL, Copenhaver AM, Humbles AA, Liu Y-J (2016) IL-1 is a critical regulator of group 2 innate lymphoid cell function and plasticity. Nat Immunol 17:646–655. https://doi.org/10.1038/ni.3447 PubMedCrossRef

79.

Huang Y, Paul WE (2015) Inflammatory group 2 innate lymphoid cells. Int Immunol 28:dxv044. https://doi.org/10.1093/intimm/dxv044 CrossRef

80.

Yu X, Wang Y, Deng M, Li Y, Ruhn KA, Zhang CC, Hooper LV (2014) The basic leucine zipper transcription factor NFIL3 directs the development of a common innate lymphoid cell precursor. elife 3. https://doi.org/10.7554/eLife.04406.

81.

Narni-Mancinelli E, Chaix J, Fenis A, Kerdiles YM, Yessaad N, Reynders A, Gregoire C, Luche H, Ugolini S, Tomasello E, Walzer T, Vivier E (2011) Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor. Proc Natl Acad Sci U S A 108:18324–18329. https://doi.org/10.1073/pnas.1112064108 PubMedPubMedCentralCrossRef

82.

Hughes T, Briercheck EL, Freud AG, Trotta R, McClory S, Scoville SD, Keller K, Deng Y, Cole J, Harrison N, Mao C, Zhang J, Benson DM, Yu J, Caligiuri MA (2014) The transcription factor AHR prevents the differentiation of a stage 3 innate lymphoid cell subset to natural killer cells. Cell Rep 8:150–162. https://doi.org/10.1016/j.celrep.2014.05.042 PubMedPubMedCentralCrossRef

83.

Raykova A, Carrega P, Lehmann FM, Ivanek R, Landtwing V, Quast I, Lünemann JD, Finke D, Ferlazzo G, Chijioke O, Münz C (2017) Interleukins 12 and 15 induce cytotoxicity and early NK-cell differentiation in type 3 innate lymphoid cells. Blood Adv 1:2679–2691. https://doi.org/10.1182/bloodadvances.2017008839 PubMedPubMedCentralCrossRef

84.

Vonarbourg C, Mortha A, Bui VL, Hernandez PP, Kiss EA, Hoyler T, Flach M, Bengsch B, Thimme R, Hölscher C, Hönig M, Pannicke U, Schwarz K, Ware CF, Finke D, Diefenbach A (2010) Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt(+) innate lymphocytes. Immunity 33:736–751. https://doi.org/10.1016/j.immuni.2010.10.017 PubMedPubMedCentralCrossRef

85.

Gao Y, Souza-Fonseca F, Guimaraes T, Bald SS, Ng A, Young SF, Ngiow J, Rautela J, Straube N, Waddell SJ, Blake J, Yan L, Bartholin JS, Lee E, Vivier K, Takeda M, Messaoudene L, Zitvogel MWL, Teng GT, Belz CR, Engwerda ND, Huntington K, Nakamura M, Hölzel MJS (2017) Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells. Nat Immunol 18:1004–1015. https://doi.org/10.1038/ni.3800. PubMedCrossRef

86.

Cortez VS, Ulland TK, Cervantes-Barragan L, Bando JK, Robinette ML, Wang Q, White AJ, Gilfillan S, Cella M, Colonna M (2017) SMAD4 impedes the conversion of NK cells into ILC1-like cells by curtailing non-canonical TGF-β signaling. Nat Immunol 18:995–1003. https://doi.org/10.1038/ni.3809. PubMedPubMedCentralCrossRef

87.

Marquardt N, Béziat V, Nyström S, Hengst J, Ivarsson MA, Kekäläinen E, Johansson H, Mjösberg J, Westgren M, Lankisch TO, Wedemeyer H, Ellis EC, Ljunggren H-G, Michaëlsson J, Björkström NK (2015) Cutting edge: identification and characterization of human intrahepatic CD49a+ NK cells. J Immunol 194:2467–2471. https://doi.org/10.4049/jimmunol.1402756 PubMedCrossRef

88.

Mortha A, Burrows K (2018) Cytokine networks between innate lymphoid cells and myeloid cells. Front Immunol 9:191. https://doi.org/10.3389/fimmu.2018.00191 PubMedPubMedCentralCrossRef

89.

Halim TYF, Steer CA, Mathä L, Gold MJ, Martinez-Gonzalez I, McNagny KM, McKenzie ANJ, Takei F (2014) Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity 40:425–435. https://doi.org/10.1016/j.immuni.2014.01.011 PubMedPubMedCentralCrossRef

90.

Halim TYF, Hwang YY, Scanlon ST, Zaghouani H, Garbi N, Fallon PG, McKenzie ANJ (2016) Group 2 innate lymphoid cells license dendritic cells to potentiate memory TH2 cell responses. Nat Immunol 17:57–64. https://doi.org/10.1038/ni.3294 PubMedCrossRef

91.

Mirchandani AS, Besnard A-G, Yip E, Scott C, Bain CC, Cerovic V, Salmond RJ, Liew FY (2014) Type 2 innate lymphoid cells drive CD4+ Th2 cell responses. J Immunol 192:2442–2448. https://doi.org/10.4049/jimmunol.1300974 PubMedCrossRef

92.

Oliphant CJ, Hwang YY, Walker JA, Salimi M, Wong SH, Brewer JM, Englezakis A, Barlow JL, Hams E, Scanlon ST, Ogg GS, Fallon PG, McKenzie ANJ (2014) MHCII-mediated dialog between group 2 innate lymphoid cells and CD4+ T cells potentiates type 2 immunity and promotes parasitic helminth expulsion. Immunity 41:283–295. https://doi.org/10.1016/j.immuni.2014.06.016 PubMedPubMedCentralCrossRef

93.

Drake LY, Iijima K, Kita H (2014) Group 2 innate lymphoid cells and CD4 ⁺ T cells cooperate to mediate type 2 immune response in mice. Allergy 69:1300–1307. https://doi.org/10.1111/all.12446 PubMedPubMedCentralCrossRef

94.

Gold MJ, Antignano F, Halim TYF, Hirota JA, Blanchet M-R, Zaph C, Takei F, McNagny KM (2014) Group 2 innate lymphoid cells facilitate sensitization to local, but not systemic, TH2-inducing allergen exposures. J Allergy Clin Immunol 133:1142–1148. https://doi.org/10.1016/j.jaci.2014.02.033 PubMedCrossRef

95.

Schwartz C, Khan AR, Floudas A, Saunders SP, Hams E, Rodewald H-R, McKenzie ANJ, Fallon PG (2017) ILC2s regulate adaptive Th2 cell functions via PD-L1 checkpoint control. J Exp Med 214:2507–2521. https://doi.org/10.1084/jem.20170051 PubMedPubMedCentralCrossRef

96.

Rauber S, Luber M, Weber S, Maul L, Soare A, Wohlfahrt T, Lin N-Y, Dietel K, Bozec A, Herrmann M, Kaplan MH, Weigmann B, Zaiss MM, Fearon U, Veale DJ, Cañete JD, Distler O, Rivellese F, Pitzalis C, Neurath MF, McKenzie ANJ, Wirtz S, Schett G, Distler JHW, Ramming A (2017) Resolution of inflammation by interleukin-9-producing type 2 innate lymphoid cells. Nat. Med 23:938–944. https://doi.org/10.1038/nm.4373 PubMedPubMedCentralCrossRef

97.

Hepworth MR, Monticelli LA, Fung TC, Ziegler CGK, Grunberg S, Sinha R, Mantegazza AR, Ma H-L, Crawford A, Angelosanto JM, Wherry EJ, Koni PA, Bushman FD, Elson CO, Eberl G, Artis D, Sonnenberg GF (2013) Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria. Nature 498:113–117. https://doi.org/10.1038/nature12240 PubMedPubMedCentralCrossRef

98.

Hepworth MR, Fung TC, Masur SH, Kelsen JR, McConnell FM, Dubrot J, Withers DR, Hugues S, Farrar MA, Reith W, Eberl G, Baldassano RN, Laufer TM, Elson CO, Sonnenberg GF (2015) Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4+ T cells. Science (80-.) 348:1031–1035. https://doi.org/10.1126/science.aaa4812 CrossRef

99.

von Burg N, Chappaz S, Baerenwaldt A, Horvath E, Bose Dasgupta S, Ashok D, Pieters J, Tacchini-Cottier F, Rolink A, Acha-Orbea H, Finke D (2014) Activated group 3 innate lymphoid cells promote T-cell-mediated immune responses. Proc Natl Acad Sci U S A 111:12835–12840. https://doi.org/10.1073/pnas.1406908111 CrossRef

100.

Korn LL, Thomas HL, Hubbeling HG, Spencer SP, Sinha R, Simkins HM, Salzman NH, Bushman FD, Laufer TM (2014) Conventional CD4+ T cells regulate IL-22-producing intestinal innate lymphoid cells. Mucosal Immunol 7:1045–1057. https://doi.org/10.1038/mi.2013.121 PubMedPubMedCentralCrossRef

101.

Mao K, Baptista AP, Tamoutounour S, Zhuang L, Bouladoux N, Martins AJ, Huang Y, Gerner MY, Belkaid Y, Germain RN (2018) Innate and adaptive lymphocytes sequentially shape the gut microbiota and lipid metabolism. Nature 554:255–259. https://doi.org/10.1038/nature25437 PubMedCrossRef

102.

Kruglov AA, Grivennikov SI, Kuprash DV, Winsauer C, Prepens S, Seleznik GM, Eberl G, Littman DR, Heikenwalder M, Tumanov AV, Nedospasov SA (2013) Nonredundant function of soluble LTα3 produced by innate lymphoid cells in intestinal homeostasis. Science 342:1243–1246. https://doi.org/10.1126/science.1243364 PubMedCrossRef

103.

Drake LY, Iijima K, Bartemes K, Kita H (2016) Group 2 innate lymphoid cells promote an early antibody response to a respiratory antigen in mice. J Immunol 197:1335–1342. https://doi.org/10.4049/jimmunol.1502669 PubMedPubMedCentralCrossRef

104.

Maggi L, Montaini G, Mazzoni A, Rossettini B, Capone M, Rossi MC, Santarlasci V, Liotta F, Rossi O, Gallo O, De Palma R, Maggi E, Cosmi L, Romagnani S, Annunziato F (2017) Human circulating group 2 innate lymphoid cells can express CD154 and promote IgE production. J Allergy Clin Immunol 139:964–976.e4. https://doi.org/10.1016/j.jaci.2016.06.032 PubMedCrossRef

105.

Magri G, Miyajima M, Bascones S, Mortha A, Puga I, Cassis L, Barra CM, Comerma L, Chudnovskiy A, Gentile M, Llige D, Cols M, Serrano S, Aróstegui JI, Juan M, Yagüe J, Merad M, Fagarasan S, Cerutti A (2014) Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. Nat Immunol 15:354–364. https://doi.org/10.1038/ni.2830 PubMedPubMedCentralCrossRef

106.

Yang J, Cornelissen F, Papazian N, Reijmers RM, Llorian M, Cupedo T, Coles M, Seddon B (2018) IL-7–dependent maintenance of ILC3s is required for normal entry of lymphocytes into lymph nodes. J Exp Med. https://doi.org/10.1084/jem.20170518

107.

Laffont S, Blanquart E, Savignac M, Cénac C, Laverny G, Metzger D, Girard J-P, Belz GT, Pelletier L, Seillet C, Guéry J-C (2017) Androgen signaling negatively controls group 2 innate lymphoid cells. J Exp Med 214:1581–1592. https://doi.org/10.1084/jem.20161807 PubMedPubMedCentralCrossRef

108.

Barnig C, Cernadas M, Dutile S, Liu X, Perrella MA, Kazani S, Wechsler ME, Israel E, Levy BD (2013) Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma. Sci Transl Med 5:174ra26. https://doi.org/10.1126/scitranslmed.3004812 PubMedCrossRef

109.

Nussbaum JC, Van Dyken SJ, von Moltke J, Cheng LE, Mohapatra A, Molofsky AB, Thornton EE, Krummel MF, Chawla A, Liang H-E, Locksley RM (2013) Type 2 innate lymphoid cells control eosinophil homeostasis. Nature 502:245–248. https://doi.org/10.1038/nature12526 PubMedPubMedCentralCrossRef

110.

Schiering C, Wincent E, Metidji A, Iseppon A, Li Y, Potocnik AJ, Omenetti S, Henderson CJ, Wolf CR, Nebert DW, Stockinger B (2017) Feedback control of AHR signalling regulates intestinal immunity. Nature 542:242–245. https://doi.org/10.1038/nature21080 PubMedPubMedCentralCrossRef

111.

von Moltke J, Ji M, Liang H-E, Locksley RM (2016) Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit. Nature 529:221–225. https://doi.org/10.1038/nature16161 CrossRef

112.

Sonnenberg GF, Fouser LA, Artis D (2011) Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat Immunol 12:383–390. https://doi.org/10.1038/ni.2025 PubMedCrossRef

113.

Bando JK, Colonna M (2016) Innate lymphoid cell function in the context of adaptive immunity. Nat Immunol 17:783–789. https://doi.org/10.1038/ni.3484 PubMedPubMedCentralCrossRef

114.

Song C, Lee JS, Gilfillan S, Robinette ML, Newberry RD, Stappenbeck TS, Mack M, Cella M, Colonna M (2015) Unique and redundant functions of NKp46+ ILC3s in models of intestinal inflammation. J Exp Med 212:1869–1882. https://doi.org/10.1084/jem.20151403 PubMedPubMedCentralCrossRef

115.

Brasseit J, Kwong Chung CKC, Noti M, Zysset D, Hoheisel-Dickgreber N, Genitsch V, Corazza N, Mueller C (2018) Divergent roles of interferon-γ and innate lymphoid cells in innate and adaptive immune cell-mediated intestinal inflammation. Front Immunol 9:23. https://doi.org/10.3389/fimmu.2018.00023 PubMedPubMedCentralCrossRef

116.

Rankin LC, Girard-Madoux MJH, Seillet C, Mielke LA, Kerdiles Y, Fenis A, Wieduwild E, Putoczki T, Mondot S, Lantz O, Demon D, Papenfuss AT, Smyth GK, Lamkanfi M, Carotta S, Renauld J-C, Shi W, Carpentier S, Soos T, Arendt C, Ugolini S, Huntington ND, Belz GT, Vivier E (2016) Complementarity and redundancy of IL-22-producing innate lymphoid cells. Nat Immunol 17:179–186. https://doi.org/10.1038/ni.3332 PubMedCrossRef

117.

Vély F, Barlogis V, Vallentin B, Neven B, Piperoglou C, Ebbo M, Perchet T, Petit M, Yessaad N, Touzot F, Bruneau J, Mahlaoui N, Zucchini N, Farnarier C, Michel G, Moshous D, Blanche S, Dujardin A, Spits H, Distler JHW, Ramming A, Picard C, Golub R, Fischer A, Vivier E (2016) Evidence of innate lymphoid cell redundancy in humans. Nat Immunol 17:1291–1299. https://doi.org/10.1038/ni.3553 PubMedPubMedCentralCrossRef

Title: The roles for innate lymphoid cells in the human immune system
Authors: L. Mazzurana
A. Rao
A. Van Acker
J. Mjösberg
Publication date: 01-07-2018
Publisher: Springer Berlin Heidelberg
Published in: Seminars in Immunopathology / Issue 4/2018
Print ISSN: 1863-2297
Electronic ISSN: 1863-2300
DOI: https://doi.org/10.1007/s00281-018-0688-7

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

ACC 2024 Congress

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2018

Memory responses of innate lymphocytes and parallels with T cells

Innate lymphoid cells—key immune integrators of overall body homeostasis

Innate lymphoid cells in autoimmunity and chronic inflammatory diseases

Activating and inhibitory receptors expressed on innate lymphoid cells